Impax Asset Management Group plc Sells 4,377 Shares of CME Group Inc. $CME

Impax Asset Management Group plc reduced its position in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 17.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 20,175 shares of the financial services provider’s stock after selling 4,377 shares during the period. Impax Asset Management Group plc’s holdings in CME Group were worth $5,285,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. Edgestream Partners L.P. purchased a new position in shares of CME Group during the third quarter valued at approximately $4,762,000. Silver Oak Securities Incorporated boosted its position in CME Group by 36.1% during the third quarter. Silver Oak Securities Incorporated now owns 3,646 shares of the financial services provider’s stock worth $955,000 after acquiring an additional 968 shares during the last quarter. Hantz Financial Services Inc. grew its stake in CME Group by 11.9% in the 3rd quarter. Hantz Financial Services Inc. now owns 2,161 shares of the financial services provider’s stock worth $566,000 after acquiring an additional 229 shares during the period. Harbour Investments Inc. grew its stake in CME Group by 41.3% in the 3rd quarter. Harbour Investments Inc. now owns 3,772 shares of the financial services provider’s stock worth $988,000 after acquiring an additional 1,102 shares during the period. Finally, Pensioenfonds Rail & OV purchased a new stake in CME Group in the 3rd quarter worth approximately $5,452,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

CME has been the subject of several analyst reports. CLSA set a $367.00 price target on CME Group in a report on Thursday, October 22nd. Weiss Ratings raised CME Group from a “buy (b)” rating to a “buy (b+)” rating in a research note on Friday, November 13th. Morgan Stanley increased their price objective on shares of CME Group from $337.00 to $359.00 and gave the stock an “overweight” rating in a report on Thursday, October 22nd. Bank of America raised their target price on shares of CME Group from $226.00 to $230.00 and gave the stock an “underperform” rating in a research report on Thursday, July 23rd. Finally, Wells Fargo & Company raised their target price on shares of CME Group from $315.00 to $333.00 and gave the stock an “overweight” rating in a research report on Thursday, October 22nd. Ten equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $314.44.

Read Our Latest Report on CME

CME Group Trading Down 0.4%

CME stock opened at $310.25 on Thursday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The company has a market cap of $111.05 billion, a price-to-earnings ratio of 25.45, a PEG ratio of 3.80 and a beta of 0.15. The business has a fifty day simple moving average of $288.15 and a 200-day simple moving average of $281.93. CME Group Inc. has a 52 week low of $218.31 and a 52 week high of $329.16.

CME Group (NASDAQ:CME – Get Free Report) last issued its earnings results on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share for the quarter, beating analysts’ consensus estimates of $2.99 by $0.03. CME Group had a return on equity of 16.23% and a net margin of 63.33%. The firm had revenue of $1.74 billion for the quarter, compared to analysts’ expectations of $1.71 billion. During the same quarter last year, the firm earned $2.68 earnings per share. The firm’s revenue for the quarter was up 10.6% compared to the same quarter last year. On average, equities research analysts expect that CME Group Inc. will post 12.35 EPS for the current year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 30th. Shareholders of record on Friday, December 11th will be paid a dividend of $1.30 per share. The ex-dividend date is Friday, December 11th. This represents a $5.20 annualized dividend and a yield of 1.7%. CME Group’s dividend payout ratio is currently 42.66%.

Insider Buying and Selling

In other news, Director Daniel G. Kaye sold 532 shares of the business’s stock in a transaction dated Monday, November 9th. The stock was sold at an average price of $304.17, for a total transaction of $161,818.44. Following the completion of the sale, the director owned 4,313 shares in the company, valued at approximately $1,311,885.21. The trade was a 10.98% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Howard J. Siegel sold 2,000 shares of the stock in a transaction that occurred on Monday, November 2nd. The stock was sold at an average price of $303.00, for a total transaction of $606,000.00. Following the sale, the director directly owned 19,873 shares of the company’s stock, valued at approximately $6,021,519. This trade represents a 9.14% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 33,511 shares of company stock worth $9,714,580. Corporate insiders own 0.30% of the company’s stock.

Recent CME Group Headlines

Investors following CME have been watching these headlines:

About CME Group

(Free Report)

CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.

See Also

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.